Lunit

Lunit Dividend per Share

Dividend per Share of Lunit (328130.KQ) as of Oct 15, 2026.

Dividend per Share

0.00KRW

Last updated:

Dividend per Share of Lunit is 2024 0.00 KRW. Dividend per Share of Lunit was 2023 0.00 KRW. It decreases by % lower compared to the previous year.

The Lunit Dividend per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Dividend per Share
Date
Dividend per Share
Jan 1, 2021
0.00 KRW
Jan 1, 2022
0.00 KRW
Jan 1, 2023
0.00 KRW
Jan 1, 2024
0.00 KRW
Jan 1, 2025 (e)
0.00 KRW
Jan 1, 2026 (e)
0.00 KRW
Jan 1, 2027 (e)
0.00 KRW
Jan 1, 2028 (e)
0.00 KRW
The Lunit Dividend per Share history
YEARDividend per ShareYoY
est0.00KRW—
est0.00KRW—
est0.00KRW—
est0.00KRW—
0.00KRW—
0.00KRW—
0.00KRW—
0.00KRW—
0.00KRW—
0.00KRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Lunit Stock analysis

What does Lunit do? Lunit Inc is a South Korean company headquartered in Seoul, operating within the Health Care sector. The company has 293 employees and went public on July 21, 2022, with its ticker listed as 328130.KQ and ISIN KR7328130000. Lunit provides software solutions for medical diagnostic imaging services, focusing on the development and supply of AI-powered medical software. Its offerings include cancer diagnostic aid solutions, cancer early detection solutions, and cancer risk prediction solutions. The company's technology leverages artificial intelligence to enhance diagnostic capabilities in healthcare settings. Lunit's website is www.lunit.io, where further information about its services and solutions can be accessed. The company operates in the Health Care industry, specifically targeting medical imaging and AI-driven diagnostic tools. As of the latest available data, Lunit is engaged in the development and commercialization of AI-based medical software, aiming to improve the accuracy and efficiency of cancer-related diagnostics. The firm's IPO date marks its transition to a publicly traded company, reflecting its growth and market position in the healthcare technology space. Lunit's focus on AI applications in medical imaging positions it as a key player in the digital health sector, particularly within the Korean market and beyond. The company's solutions are designed to support healthcare professionals in making more informed diagnostic decisions, potentially reducing the time and resources required for cancer detection and treatment planning. Lunit is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Lunit stock

On Eulerpool you can find the complete historical development of Dividend per Share Lunit since 2006 – with annual values, charts, and detailed analysis.

Dividend per share is the total dividend payment divided by shares outstanding. It shows how much cash each share receives in dividends.

Dividend per Share's KRW is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Dividend per Share's Lunit historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Dividend — Lunit

All Key Metrics — Lunit